Multiple Sclerosis

Cannabis and Multiple Sclerosis: What Research Says About Symptom Management

Explore how cannabis and multiple sclerosis are linked through emerging research on its potential role in easing MS-related symptoms. This page highlights recent studies and patient experiences, demonstrating how medical cannabis may help with pain, spasticity, and quality of life in people living with multiple sclerosis.

Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Biochemical and Biophysical Research Communications (2019)

Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis Multiple Sclerosis and Related Disorders (2021)

Patterns of Medical Cannabis Use Among Patients Diagnosed with Multiple Sclerosis Multiple Sclerosis and Related Disorders (2021)

Multiple Sclerosis, Cannabis Use, and Clinical Disability Cannabis and Cannabinoid Research (2018)

Cannabinoids and bladder symptoms in multiple sclerosis Multiple Sclerosis and Related Disorders (2021)

Medical cannabis use in Canadians with multiple sclerosis Multiple Sclerosis and Related Disorders (2022)

Are Cannabis and Cannabinoids Effective for Symptomatic Treatment in People with Multiple Sclerosis American Journal of Physical Medicine & Rehabilitation (2023)

Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review of a Neurology Outpatient Population International Journal of MS Care (2023)

Vaporized Cannabis Provides “Significant Improvements” for Multiple Sclerosis Patients Journal of Clinical Medicine (2025)